Biotech man defends his pounds 1.5m share option profit

Cash gains: Research head at cancer drug group reveals Lloyd's losses 8 Former ad agency chiefs make pounds 10m in multimedia launch

Peter Lewis, head of research and development at British Biotech, yesterday defended his decision to cash in share options just days after the group announced a potential breakthrough in cancer treatment.

Since the news, the shares have soared from pounds 10.43, with one deal going through at pounds 25 last week. Mr Lewis's sale at pounds 17.60 a share netted him a pounds 1.5m profit, with fellow board member James Noble making a further pounds 1.7m from option sales yesterday. The shares closed last night down 110p at pounds 16.08.

Speaking from the company's Oxford base yesterday, Dr Lewis said the options "represented 90 per cent of my financial position and I had to shelter some of my position, as it were. I still think it is a very good company and think the shares will go up further, but I felt I had to protect my position."

Dr Lewis said he had "a very good reason" for raising the cash now as a loss-making name at the Lloyd's of London insurance market. He faces a cash call next year from the new Equitas reinsurance vehicle designed to protect names from huge past losses.

He admitted that the sale "looks unusual", but said that companies like British Biotech were more usual in the US and similar option sales were "a very, very common occurrence" there. He suggested that British Biotech was already looking like US success stories, such as Amgen and Genentech, which had been built up from scratch.

Dr Lewis was previously vice-president of product development at Marion Merrell Dow, a big US pharmaceuticals group. "The fact of the matter is I consider that these options were part of the package which took me to the company in the first place", he said. "I wouldn't have come without them." Dr Lewis claimed they were part of the "entrepreneurial start-up culture" of a company like British Biotech.

Dr Lewis exercised his right to convert 106,695 options at 337p a share. He immediately sold 106,000 at the prevailing market price of pounds 17.60, making a profit of pounds 1.5m on the deal. Mr Noble, finance director, exercised 106,695 at 187p and a further 16,000 at 337p. His sale of 110,000 shares left him with a gain of pounds 1.7m.

The company's shares soared 48 per cent last Thursday, adding pounds 244m to its stock market value, after it announced what may be a breakthrough in the treatment of cancer. One deal in the shares went through at over pounds 26 last week, but since then the share price has fallen back, not helped by the news of directors' dealings.

City analysts have become excited by the prospects for Marimastat, an oral drug which has shown some effectiveness in halting the growth or reducing the size of cancerous tumours in trials. Some estimates have suggested eventual revenues could top $1bn.

However, the results, covering 94 late-stage cancer patients, are only preliminary and the drug has a long way to go before gaining approval from the regulatory authorities. Meanwhile, British Biotech, which was floated at 425p a share in 1992, has yet to show a profit or pay its investors a dividend.

PROMOTED VIDEO
News
Angelina Jolie with her father Jon Voight
people
News
Bill Kerr has died aged 92
people
Life and Style
A picture taken on January 12, 2011 shows sex shops at the Paris district of Pigalle.
news
Sport
footballPremiership preview: All the talking points ahead of this weekend's matches
News
Keira Knightley poses topless for a special September The Photographer's issue of Interview Magazine, out now
people
Voices
The Ukip leader has consistently refused to be drawn on where he would mount an attempt to secure a parliamentary seat
voicesNigel Farage: Those who predicted we would lose momentum heading into the 2015 election are going to have to think again
News
ebooksAn evocation of the conflict through the eyes of those who lived through it
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

SAS Business Analyst - Credit Risk - Retail Banking

£450 - £500 per day: Orgtel: SAS Business Analyst, London, Banking, Credit Ris...

Project Manager - Pensions

£32000 - £38000 Per Annum Bonus, Life Insurance + Other Benefits: Clearwater P...

KYC Analyst, Birmingham - £200-£250 p/d

£200 - £250 per day + competitive: Orgtel: KYC Analyst, Key Banking Client, Bi...

Test Manager - Banking - Yorkshire - £450 per day

£400 - £500 per day: Orgtel: Test Manager - Banking - West Yorkshire - £400-£5...

Day In a Page

Ukraine crisis: The phoney war is over as Russian troops and armour pour across the border

The phoney war is over

Russian troops and armour pour into Ukraine
Potatoes could be off the menu as crop pests threaten UK

Potatoes could be off the menu as crop pests threaten UK

The world’s entire food system is under attack - and Britain is most at risk, according to a new study
Gangnam smile: why the Chinese are flocking to South Korea to buy a new face

Gangnam smile: why the Chinese are flocking to South Korea to buy a new face

Seoul's plastic surgery industry is booming thanks to the popularity of the K-Pop look
From Mozart to Orson Welles: Creative geniuses who peaked too soon

Creative geniuses who peaked too soon

After the death of Sandy Wilson, 90, who wrote his only hit musical in his twenties, John Walsh wonders what it's like to peak too soon and go on to live a life more ordinary
Caught in the crossfire of a cyber Cold War

Caught in the crossfire of a cyber Cold War

Fears are mounting that Vladimir Putin has instructed hackers to target banks like JP Morgan
Salomé's feminine wiles have inspired writers, painters and musicians for 2,000 years

Salomé: A head for seduction

Salomé's feminine wiles have inspired writers, painters and musicians for 2,000 years. Now audiences can meet the Biblical femme fatale in two new stage and screen projects
From Bram Stoker to Stanley Kubrick, the British Library's latest exhibition celebrates all things Gothic

British Library celebrates all things Gothic

Forthcoming exhibition Terror and Wonder: The Gothic Imagination will be the UK's largest ever celebration of Gothic literature
The Hard Rock Café's owners are embroiled in a bitter legal dispute - but is the restaurant chain worth fighting for?

Is the Hard Rock Café worth fighting for?

The restaurant chain's owners are currently embroiled in a bitter legal dispute
Caribbean cuisine is becoming increasingly popular in the UK ... and there's more to it than jerk chicken at carnival

In search of Caribbean soul food

Caribbean cuisine is becoming increasingly popular in the UK ... and there's more to it than jerk chicken at carnival
11 best face powders

11 best face powders

Sweep away shiny skin with our pick of the best pressed and loose powder bases
England vs Norway: Roy Hodgson's hands tied by exploding top flight

Roy Hodgson's hands tied by exploding top flight

Lack of Englishmen at leading Premier League clubs leaves manager hamstrung
Angel Di Maria and Cristiano Ronaldo: A tale of two Manchester United No 7s

Di Maria and Ronaldo: A tale of two Manchester United No 7s

They both inherited the iconic shirt at Old Trafford, but the £59.7m new boy is joining a club in a very different state
Israel-Gaza conflict: No victory for Israel despite weeks of death and devastation

Robert Fisk: No victory for Israel despite weeks of devastation

Palestinians have won: they are still in Gaza, and Hamas is still there
Mary Beard writes character reference for Twitter troll who called her a 'slut'

Unlikely friends: Mary Beard and the troll who called her a ‘filthy old slut’

The Cambridge University classicist even wrote the student a character reference
America’s new apartheid: Prosperous white districts are choosing to break away from black cities and go it alone

America’s new apartheid

Prosperous white districts are choosing to break away from black cities and go it alone